This schedule allows your doctor to catch any medication dosing changes early and prevents hypothyroid or hyperthyroid symptoms from developing during weight loss
Combining Rybelsus with a balanced diet and regular exercise can further enhance weight loss outcomes

Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK Lymphadenopathy is not listed in the Summary of Product Characteristics or reported in SURPASS or SURMOUNT clinical trials Common Mounjaro side effects are predominantly gastrointestinal, including nausea, vomiting, diarrhoea, and reduced appetite Lymph node swelling during treatment may result from infections, vaccinations, local inflammation, or other unrelated conditions Persistent, enlarging, or hard lymph nodes require GP evaluation to exclude serious underlying causes including malignancy Report any suspected adverse effects through the MHRA Yellow Card Scheme for ongoing pharmacovigilance monitoring Table of Contents Understanding Mounjaro and Its Common Side Effects Mounjaro (tirzepatide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus

A thoughtful and comprehensive nutrition and lifestyle program can help address these challenges and increase the efficacy and cost-effectiveness of GLP-1s
The length of a needle determines how far into your skin it penetrates
Symptoms include difficulty breathing, facial or throat swelling, rapid heartbeat, hives, and a sudden drop in blood pressure